Stay updated on CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.

Latest updates to the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 31, 2024.SummaryDifference1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.